NASDAQ:SURG

SurgePays - SURG Stock Forecast, Price & News

$6.36

+0.15 (+2.42%)

(As of 11/29/2022 12:00 AM ET)

Add

Compare

Today's Range: $6.23
▼
$6.40
50-Day Range: $4.55
▼
$6.36
52-Week Range: $1.76
▼
$7.30

Volume: 68,073 shs
Average Volume: 140,068 shs
Market Capitalization: $77.83 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $8.38

SurgePays MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 31.8% Upside
$8.38 Price Target
Short Interest: Bearish
13.43% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.64
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.51 out of 5 stars

Computer And Technology Sector

593rd out of 632 stocks

Advertising Industry

10th out of 10 stocks

3.5

Analyst's Opinion

Consensus Rating
SurgePays has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $8.38, SurgePays has a forecasted upside of 31.8% from its current price of $6.36.
Amount of Analyst Coverage
SurgePays has received no research coverage in the past 90 days.

0.0

Short Interest

Percentage of Shares Shorted
13.43% of the float of SurgePays has been sold short.
Short Interest Ratio / Days to Cover
SurgePays has a short interest ratio ("days to cover") of 13.1, which indicates bearish sentiment.
Change versus previous month
Short interest in SurgePays has recently increased by 10.00%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
SurgePays does not currently pay a dividend.
Dividend Growth
SurgePays does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for SURG.

3.1

News and Social Media Coverage

News Sentiment
SurgePays has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Computer and Technology companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for SurgePays this week, compared to 2 articles on an average week.
Search Interest
9 people have searched for SURG on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
MarketBeat Follows
5 people have added SurgePays to their MarketBeat watchlist in the last 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, SurgePays insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 7.13% of the stock of SurgePays is held by institutions.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of SurgePays is -5.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of SurgePays is -5.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
SurgePays has a P/B Ratio of 21.91. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About SurgePays (NASDAQ:SURG) Stock

SurgePays, Inc., a financial technology and telecommunications company, provides services to the underbanked community in the United States. Its blockchain platform utilizes a suite of financial and prepaid products to convert corner stores and bodegas into tech-hubs for underbanked neighborhoods. The company offers voice and SMS text messaging services to subsidized and direct retail prepaid customers, as well as to low-income consumers. It also offers subsidized mobile broadband services to consumers in California, Colorado, Florida, Illinois, Maryland, Mississippi, Missouri, Nevada, New Jersey, Ohio, Oklahoma, Rhode Island, Tennessee, and Texas, as well as prepaid wireless plans. In addition, the company provides marketing business intelligence, plaintiff generation, and case load management solutions primarily to law firms in the mass tort industry. Further, it operates a bilingual operations center offering the Company with sales support, customer service, IT infrastructure design, graphic media, database programming, software development, revenue assurance, lead generation, and other various operational support services. The company is headquartered in Bartlett, Tennessee.

Receive SURG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SurgePays and its competitors with MarketBeat's FREE daily newsletter.

SURG Stock News Headlines

November 25, 2022 | americanbankingnews.com

Financial Analysis: Starbox Group (NASDAQ:STBX) versus SurgePays (NASDAQ:SURG)

November 18, 2022 | finance.yahoo.com

SurgePays Announces Closing on $25 Million Senior Credit Facility

November 14, 2022 | finance.yahoo.com

SurgePays Announces Third Quarter 2022 Financial Results

November 4, 2022 | finance.yahoo.com

SurgePays Announces Third Quarter 2022 Earnings Release and Conference Call

November 3, 2022 | finance.yahoo.com

SurgePays Announces Application for Dual Listing on Upstream

November 1, 2022 | finance.yahoo.com

Jeremy Gies Appointed President of SurgePays Fintech

October 27, 2022 | finance.yahoo.com

GPOPlus+ Signs Master Services Agreement with SurgePays

October 10, 2022 | uk.investing.com

TOP Ships, Weber And 3 More Short Squeeze Stocks That Could Soar This Week By Benzinga - Investing.com UK

October 10, 2022 | benzinga.com

TOP Ships, Weber And 3 More Short Squeeze Stocks That Could Soar This Week - Greenwich LifeSciences (NASD - Benzinga

October 7, 2022 | nasdaq.com

SurgePays (NASDAQ:SURG) Is Carrying A Fair Bit Of Debt - Nasdaq

October 7, 2022 | marketwatch.com

SurgePays Shares Rise 11% After Subscriber Base Passes 200,000

October 6, 2022 | ca.investing.com

After-Hours Movers: Richardson Electronics Gains on EPS, Viavi Up on Buy Rating By Investing.com - Investing.com Canada

October 6, 2022 | seekingalpha.com

SurgePays Is Ripe For A Short Squeeze (NASDAQ:SURG) - Seeking Alpha

October 5, 2022 | investing.com

After-Hours Movers: Richardson Electronics Gains on EPS, Viavi Up on Buy Rating By Investing.com - Investing.com

October 5, 2022 | globenewswire.com

SurgePays Passes 200,000 Mobile Broadband Subscribers - GlobeNewswire

October 5, 2022 | finance.yahoo.com

SurgePays Passes 200,000 Mobile Broadband Subscribers

October 3, 2022 | benzinga.com

Grenwich LilfeSciences, Blue Apron And 3 More Short Squeeze Candidates That May Soar - Blue Apron Hldgs ( - Benzinga

October 3, 2022 | globenewswire.com

SurgePays Announces Upcoming Investor Conference Participation - GlobeNewswire

October 3, 2022 | finance.yahoo.com

SurgePays Announces Upcoming Investor Conference Participation

September 29, 2022 | 247wallst.com

These Are The 10 Best-Performing Packaged Software Companies In 2022 - 24/7 Wall St.

September 24, 2022 | fool.com

SurgePays, Inc. (NASDAQ: SURG)

September 19, 2022 | benzinga.com

5 Short Squeeze Stocks That Could Soar: NeruoBo Pharmaceuticals, FaZe Holdings And More - FaZe Holdings (NASDAQ:FAZE), Greenwich LifeSciences (NASDAQ:GLSI) - Benzinga

September 19, 2022 | investorplace.com

NRBO, FAZE: The Top 5 Short Squeeze Stocks to Watch This Week - InvestorPlace

September 13, 2022 | nasdaq.com

Is Penny Stock SurgePays (NASDAQ:SURG) a Good Buy?

September 12, 2022 | nasdaq.com

Is Penny Stock SurgePays (NASDAQ:SURG) a Good Buy? - Nasdaq

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SURG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SurgePays and its competitors with MarketBeat's FREE daily newsletter.

SURG Company Calendar

Last Earnings: 10/14/2015
Today: 11/29/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Advertising
Sub-Industry: N/A
Sector: Computer and Technology
Current Symbol: NASDAQ:SURG
CUSIP: N/A
CIK: 836429
Web: www.surgeholdings.com
Phone: (901) 302-9587
Fax: N/A
Employees: 32
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $8.38
High Stock Price Forecast: $8.75
Low Stock Price Forecast: $8.00
Forecasted Upside/Downside: +31.8%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.17)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-13,530,000.00
Net Margins: -10.58%
Pretax Margin: -10.79%
Return on Equity: -492.78%
Return on Assets: -42.02%

Debt

Debt-to-Equity Ratio: 11.98
Current Ratio: 1.00
Quick Ratio: 0.65

Sales & Book Value

Annual Sales: $51.06 million
Price / Sales: 1.52
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.29 per share
Price / Book: 21.91

Miscellaneous

Outstanding Shares: 12,247,000
Free Float: N/A
Market Cap: $77.83 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Kevin Brian Cox (Age 47)
Chairman & CEO
Comp: $772.09k

Mr. Anthony George Evers CPA (Age 58)
CIA, CPA, CFO & Acting COO
Comp: $411.21k

Mr. David C. Ansani J.D. (Age 57)
M.B.A., Chief Legal Counsel, Sec. & Chief Admin. Officer
Comp: $267.55k

Mr. John Mott
Chief Technology Officer

Mr. Carter M. Matzinger (Age 47)
Chief Strategic Officer of LogicsIQ

Mr. Brian M. Prenoveau C.F.A.
Managing Director of MZ

Mr. Jeremy Gies
Pres of SurgePays Fintech, Inc.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SURG Stock - Frequently Asked Questions

Should I buy or sell SurgePays stock right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for SurgePays in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SURG shares.
View SURG analyst ratings or view top-rated stocks.
What is SurgePays' stock price forecast for 2023?: 2 Wall Street research analysts have issued 1-year target prices for SurgePays' shares. Their SURG share price forecasts range from $8.00 to $8.75. On average, they predict the company's share price to reach $8.38 in the next twelve months. This suggests a possible upside of 31.8% from the stock's current price.
View analysts price targets for SURG or view top-rated stocks among Wall Street analysts.
How have SURG shares performed in 2022?: SurgePays' stock was trading at $2.02 at the beginning of the year. Since then, SURG shares have increased by 214.6% and is now trading at $6.3550.
View the best growth stocks for 2022 here.
How were SurgePays' earnings last quarter?: SurgePays, Inc. (NASDAQ:SURG) released its quarterly earnings data on Wednesday, October, 14th. The medical equipment provider reported $0.06 EPS for the quarter, meeting analysts' consensus estimates of $0.06. SurgePays had a negative trailing twelve-month return on equity of 492.78% and a negative net margin of 10.58%.
What guidance has SurgePays issued on next quarter's earnings?: SurgePays issued an update on its FY 2022 earnings guidance on Friday, September, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $130.00M-, compared to the consensus revenue estimate of $126.97 million.

What other stocks do shareholders of SurgePays own?: Based on aggregate information from My MarketBeat watchlists, some companies that other SurgePays investors own include Agilent Technologies (A), Allena Pharmaceuticals (ALNA), Catalyst Biosciences (CBIO), Celldex Therapeutics (CLDX), Genocea Biosciences (GNCA), GTX (GTXI), Idera Pharmaceuticals (IDRA), Microbot Medical (MBOT), Progenics Pharmaceuticals (PGNX) and Rigel Pharmaceuticals (RIGL).
What is SurgePays' stock symbol?: SurgePays trades on the NASDAQ under the ticker symbol "SURG."
Who are SurgePays' major shareholders?: SurgePays' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (3.34%), Ridgewood Investments LLC (0.40%), Jane Street Group LLC (0.26%), State Street Corp (0.21%), Marshall Wace LLP (0.13%) and Simplex Trading LLC (0.00%). Insiders that own company stock include David Allen May, John Mott and Kevin Brian Cox.
View institutional ownership trends.
How do I buy shares of SurgePays?: Shares of SURG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is SurgePays' stock price today?: One share of SURG stock can currently be purchased for approximately $6.36.
How much money does SurgePays make?: SurgePays (NASDAQ:SURG) has a market capitalization of $77.83 million and generates $51.06 million in revenue each year. The medical equipment provider earns $-13,530,000.00 in net income (profit) each year or ($1.17) on an earnings per share basis.
How can I contact SurgePays?: SurgePays' mailing address is 3845 Corporate Centre Dr, O'FALLON, MO 63368-8678, United States. The official website for the company is www.surgeholdings.com. The medical equipment provider can be reached via phone at (901) 302-9587 or via email at invest@surgepays.com.

This page (NASDAQ:SURG) was last updated on 11/29/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial